Research project
101119427 eRaDicate
Innovative ligands for nuclear receptors to eradicate cancer relapse. (eRaDicate)
date_range
Duration: from 01 January 2024 to 31 December 2027
(48 months)
With a Private character. It has been granted under a regime of Competitive.
In collaboration with other entities.
Call:
1024
HORIZON-MSCA-2022-DN-01
Program:
Pillar 1-Excellent Science
Subprogram:
Marie Sklodowska-Curie Actions (MSCA)
